Adaptive Biotechnologies Corp ADPT:NASDAQ

RT Quote | NASDAQ | USD
Last | 06/23/21 EDT
40.96quote price arrow up+1.26 (+3.17%)
Volume
498,796
52 week range
30.41 - 71.25

...

Loading . . .
  • Open39.87
  • Day High41.46
  • Day Low39.65
  • Prev Close40.96
  • 52 Week High71.25
  • 52 Week High Date01/19/21
  • 52 Week Low30.41
  • 52 Week Low Date05/11/21

Key Stats

  • Market Cap5.747B
  • Shares Out140.31M
  • 10 Day Average Volume0.60M
  • Dividend-
  • Dividend Yield-
  • Beta-
  • YTD % Change-30.73

KEY STATS

  • Open39.87
  • Day High41.46
  • Day Low39.65
  • Prev Close40.96
  • 52 Week High71.25
  • 52 Week High Date01/19/21
  • 52 Week Low30.41
  • 52 Week Low Date05/11/21
  • Market Cap5.747B
  • Shares Out140.31M
  • 10 Day Average Volume0.60M
  • Dividend-
  • Dividend Yield-
  • Beta-
  • YTD % Change-30.73

RATIOS/PROFITABILITY

  • EPS (TTM)-1.15
  • P/E (TTM)-35.48
  • Fwd P/E (NTM)-24.78
  • EBITDA (MRQ)-150.312M
  • ROE (MRQ)-24.35%
  • Revenue (MRQ)115.91M
  • Gross Margin (MRQ)76.55%
  • Net Margin (MRQ)-134.12%
  • Debt To Equity (MRQ)0.00%

EVENTS

  • Earnings Date08/09/2021
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Adaptive Biotechnologies Corp

There is no recent news for this security.

Profile

MORE
Adaptive Biotechnologies Corp is a biotechnology company. The Company is focused on using the biology of the adaptive immune system to develop the diagnosis and treatment of disease. Its immune medicine platform generates clinical immunomics data to decode the adaptive immune system. Its products and pipeline includes immunoSEQ, clonoSEQ and cellular therapy. It offers its immunoSEQ technology as a service and a kit. immunoSEQ utilizes bias-controlled polymerase chain...
Chad Robins
Chairman
Julie Rubinstein
President
Mark Adams
Chief Operating Officer
Chad Cohen
Chief Financial Officer
Address
1551 Eastlake Ave E Ste 200
Seattle, WA
98102-7402
United States

Top Peers

SYMBOLLASTCHG%CHG
TWST
Twist Bioscience Corp
120.14+1.35+1.14%
PACB
Pacific Biosciences of California Inc
31.40+1.15+3.80%
BHVN
Biohaven Pharmaceutical Holding Company Ltd
97.72+0.52+0.53%
VIR
Vir Biotechnology Inc
47.10-0.57-1.20%
NTLA
Intellia Therapeutics Inc
83.59+4.68+5.93%